Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia Metzgeroth

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Leukemia Research|March 18, 2018
Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDSTobias Boch, Thomas Luft, Georgia Metzgeroth, et al.
Genes, Chromosomes & Cancer|April 29, 2014
Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasmsDarko Gosenca, Beate Kellert, Georgia Metzgeroth, et al.
Scientific Reports|July 18, 2025
Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1Nicole Naumann, Vito Dangelo, Johannes Lübke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based AnalysisJohannes Lübke, Juliana Schwaab, Nicole Naumann, et al.
Annals of Hematology|September 28, 2014
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genesJuliana Schwaab, Marcin Knut, Claudia Haferlach, et al.
Scientific Reports|August 20, 2022
Functional imaging with dual-energy computed tomography for supplementary non-invasive assessment of mast cell burden in systemic mastocytosisJulia Riffel, Johannes Lübke, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|September 11, 2015
Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia-associated myeloproliferative neoplasmsNicole Naumann, Juliana Schwaab, Georgia Metzgeroth, et al.
Nature Communications|October 26, 2021
Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivoJohann-Christoph Jann, Maximilian Mossner, Vladimir Riabov, et al.
Blood|April 24, 2009
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasmsFrancis H Grand, Claire E Hidalgo-Curtis, Thomas Ernst, et al.
Annals of Hematology|November 28, 2013
The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosisPhilipp Erben, Juliana Schwaab, Georgia Metzgeroth, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Leukemia Research|March 18, 2018
Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDSTobias Boch, Thomas Luft, Georgia Metzgeroth, et al.
Genes, Chromosomes & Cancer|April 29, 2014
Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasmsDarko Gosenca, Beate Kellert, Georgia Metzgeroth, et al.
Scientific Reports|July 18, 2025
Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1Nicole Naumann, Vito Dangelo, Johannes Lübke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based AnalysisJohannes Lübke, Juliana Schwaab, Nicole Naumann, et al.
Annals of Hematology|September 28, 2014
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genesJuliana Schwaab, Marcin Knut, Claudia Haferlach, et al.
Scientific Reports|August 20, 2022
Functional imaging with dual-energy computed tomography for supplementary non-invasive assessment of mast cell burden in systemic mastocytosisJulia Riffel, Johannes Lübke, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|September 11, 2015
Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia-associated myeloproliferative neoplasmsNicole Naumann, Juliana Schwaab, Georgia Metzgeroth, et al.
Nature Communications|October 26, 2021
Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivoJohann-Christoph Jann, Maximilian Mossner, Vladimir Riabov, et al.
Blood|April 24, 2009
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasmsFrancis H Grand, Claire E Hidalgo-Curtis, Thomas Ernst, et al.
Annals of Hematology|November 28, 2013
The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosisPhilipp Erben, Juliana Schwaab, Georgia Metzgeroth, et al.
Pageof 9